🔬 Mahalliy ilm-fan hamkorligining yana bir yutug‘i! 🎉
2022-yilda Fanlar akademiyasi Biorganik kimyo instituti katta ilmiy xodimi Muzaffar Qayumov bilan kompyuter modellashtirish ishlarini boshladik. Institut olimlari Rutan dorisini sintez qilib, uni COVID-19 virusiga qarshi eksperimental sinovdan o‘tkazishgan. Natijalar shuni ko‘rsatdiki, Rutan virus faolligini samarali ravishda to‘xtatdi! 🦠❌
Biz esa Rutan hosilalarini 3CL proteaz oqsili bilan docking qilib, ularning bog‘lanish erkin energiyasini hisobladik. Hisob-kitob natijalari eksperimental ma'lumotlar bilan mos keldi, molekulyar mexanizm aniqlandi! 🔬📊
Bugun ushbu muvaffaqiyatli ilmiy tadqiqotimiz Frontiers in Pharmacology jurnalida chop etildi! 🎉
Bu mahalliy ilmiy hamkorlikning ajoyib natijasi, ayniqsa Muzaffar Qayyumovning sabr-toqat bilan modellashtirishni o‘zlashtirib, yaxshi natijaga erishgani e’tiborga loyiq.
Shuningdek, hamkorimiz Parthiban Marimuthuni va butun jamoani ushbu yutuq bilan tabriklayman! 🎊👏
🔬 Mahalliy ilm-fan hamkorligining yana bir yutug‘i! 🎉
2022-yilda Fanlar akademiyasi Biorganik kimyo instituti katta ilmiy xodimi Muzaffar Qayumov bilan kompyuter modellashtirish ishlarini boshladik. Institut olimlari Rutan dorisini sintez qilib, uni COVID-19 virusiga qarshi eksperimental sinovdan o‘tkazishgan. Natijalar shuni ko‘rsatdiki, Rutan virus faolligini samarali ravishda to‘xtatdi! 🦠❌
Biz esa Rutan hosilalarini 3CL proteaz oqsili bilan docking qilib, ularning bog‘lanish erkin energiyasini hisobladik. Hisob-kitob natijalari eksperimental ma'lumotlar bilan mos keldi, molekulyar mexanizm aniqlandi! 🔬📊
Bugun ushbu muvaffaqiyatli ilmiy tadqiqotimiz Frontiers in Pharmacology jurnalida chop etildi! 🎉
Bu mahalliy ilmiy hamkorlikning ajoyib natijasi, ayniqsa Muzaffar Qayyumovning sabr-toqat bilan modellashtirishni o‘zlashtirib, yaxshi natijaga erishgani e’tiborga loyiq.
Shuningdek, hamkorimiz Parthiban Marimuthuni va butun jamoani ushbu yutuq bilan tabriklayman! 🎊👏
Start with a fresh view of investing strategy. The combination of risks and fads this quarter looks to be topping. That means the future is ready to move in.Likely, there will not be a wholesale shift. Company actions will aim to benefit from economic growth, inflationary pressures and a return of market-determined interest rates. In turn, all of that should drive the stock market and investment returns higher.
That strategy is the acquisition of a value-priced company by a growth company. Using the growth company's higher-priced stock for the acquisition can produce outsized revenue and earnings growth. Even better is the use of cash, particularly in a growth period when financial aggressiveness is accepted and even positively viewed.he key public rationale behind this strategy is synergy - the 1+1=3 view. In many cases, synergy does occur and is valuable. However, in other cases, particularly as the strategy gains popularity, it doesn't. Joining two different organizations, workforces and cultures is a challenge. Simply putting two separate organizations together necessarily creates disruptions and conflicts that can undermine both operations.
